構造に基づく
Different product structures determine different functions. For example, compounds with covalent reactive groups can bind irreversibly to target through covalent bonds which can lead to the development of highly selective inhibitors and overcome drug resistance. Nucleoside and nucleotide analogues can mimic their physiological counterparts and subsequently be incorporated into DNA and RNA to inhibit cellular division and viral replication. Nucleoside and nucleotide analogues can be used to inhibit cancer cell growth, viral replication as well as other indications.
According to different product structures, MCE carefully prepared several libraries classified by structures, such as Covalent Screening Library, Macrocyclic Compound Library, Nucleotide Compound Library, etc.
-
環状ペプチドライブラリ100 compoundsHY-L110
-
ペプチドライブラリ2,678 compoundsHY-L105
-
ヌクレオチド化合物ライブラリ592 compoundsHY-L044
-
脂質化合物ライブラリ2,071 compoundsHY-L043
-
配糖体化合物ライブラリ919 compoundsHY-L042
-
複素環式化合物ライブラリ6,552 compoundsHY-L138
-
大環状化合物ライブラリ473 compoundsHY-L041
-
共有結合スクリーニングライブラリ Plus6,151 compoundsHY-L036P
-
共有結合スクリーニングライブラリ1,624 compoundsHY-L036
-
ペプチドミメティックライブラリ371 compoundsHY-L033
-
システイン標的共有結合化合物ライブラリ5,324 compoundsHY-L153
-
ボロン酸化合物ライブラリ166 compoundsHY-L167
-
Peptide Compound Library877 compoundsHY-L105S
-
Dipeptide Compound Library73 compoundsHY-L255
-
脂肪酸化合物ライブラリ427 compoundsHY-L182
-
システイン標的共有結合フラグメント3,783 compoundsHY-L154
-
Ionizable Lipid Compound Library91 compoundsHY-L251